Skip to main content

Table 1 Patient Characteristics

From: Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL)

  

Overall

Freq

%

Treatment

Freq

%

No Treatment

Freq

%

P Value

Total

 

7,048

100

5,887

83.5

1,161

16.5

 

Age

        
 

66-69

985

14.0

889

15.1

96

8.3

 
 

70-74

1,576

22.4

1,384

23.5

192

16.5

< 0.0001

 

75-79

1,742

24.7

1,497

25.4

245

21.1

 
 

≥ 80

2,745

38.9

2,117

36.0

628

54.1

 
 

Median Age

77

72-82

77

72-82

80

75-86

 

Gender

        
 

Male

3,228

45.8

2,685

45.6

543

46.8

< 0.01

 

Female

3,820

54.2

3,202

54.4

618

53.2

 

Race

        
 

Black

240

3.4

171

2.9

59

5.1

 
 

Other

632

9.0

489

8.3

110

9.5

0.01

 

White

6,176

87.6

5,184

88.1

992

85.4

 

Stage at diagnosis

        
 

I

2,182

31.0

1,838

31.2

344

29.6

 
 

II

1,330

18.9

1,158

19.7

172

14.8

 
 

III

1,009

14.3

866

14.7

143

12.3

< 0.0001

 

IV

2,044

28.4

1,661

28.2

383

33.0

 
 

unknown

483

6.9

364

6.2

119

10.2

 

Histology

      

0.0

 
 

Centroblastic

6,902

97.9

5,773

98.1

1,129

97.2

0.07

 

Immunoblastic

146

2.1

114

1.9

32

2.8

 

Lymph node site

        
 

Extranodal

4,218

59.8

3,486

59.2

732

63.0

< 0.0001

 

Nodal

2,347

33.3

2,037

34.6

310

26.7

 
 

Unkown

483

6.9

364

6.2

119

10.2

 

NCI Comorbidity Index

        
 

0

4,075

57.8

3,458

58.7

617

53.1

< 0.0001

 

1

1,729

24.5

1,453

24.7

276

23.8

 
 

2

707

10.0

579

9.8

128

11.0

 
 

≥ 3

537

7.6

397

6.7

140

12.1

 

Year of diagnosis

        
 

2001

1,300

18.4

1,065

18.1

235

20.2

 
 

2002

1,395

19.8

1,160

19.7

235

20.2

< 0.01

 

2003

1,445

20.5

1,237

21.0

208

17.9

 
 

2004

1,465

20.8

1,230

20.9

235

20.2

 
 

2005

1,443

20.5

1,195

20.3

248

21.4

 

SEER region

        
 

CT

435

6.2

365

6.2

70

6.0

 
 

Detroit

482

6.8

409

6.9

73

6.3

 
 

HI

84

1.2

70

1.2

14

1.2

 
 

IA

526

7.5

453

7.7

73

6.3

 
 

NM

166

2.4

133

2.3

33

2.8

 
 

Seattle

397

5.6

331

5.6

66

5.7

< 0.01

 

UT

253

3.6

206

3.5

47

4.0

 
 

Atlanta

184

2.6

NS

NS

NS

NS

 
 

Rural GA

20

0.3

NS

NS

NS

NS

 
 

KY

614

8.7

496

8.4

118

10.2

 
 

LA

506

7.2

419

7.1

87

7.5

 
 

NJ

1,223

17.4

1,045

17.8

178

15.3

 
 

CA

2,158

30.6

1,788

30.4

370

31.9

 

Percent of 25+ year olds in census tract with some college

       

0.87

 

0-< 25%

2,535

36.0

2,127

36.1

408

35.1

 
 

≥ 25%

4,513

64.0

3,760

63.9

753

64.9

 

Urban vs.rural

        
 

Big Metro

3,867

54.9

3,256

55.3

611

52.6

 
 

Metro

2,071

29.4

1,708

29.0

363

31.3

0.33

 

Urban

410

5.8

342

5.8

68

5.9

 
 

Less Urban

570

8.1

470

8.0

100

8.6

 
 

Rural

130

1.8

111

1.9

19

1.6

 

Percent living in poverty in census tract

        
 

Missing

38

0.5

NS

NS

NS

NS

 
 

0-< 5%

2,311

32.8

NS

NS

NS

NS

0.05

 

5-< 7%

978

13.9

811

13.8

167

14.4

 
 

7-< 12%

1,552

22.0

1306

22.2

246

21.2

 
 

≥ 12%

2,169

30.8

1762

29.9

407

35.1

 

Other conditions

        
 

Anemia

652

9.3

501

8.5

151

13.0

< 0.0001

 

Neutropenia

14

0.2

NS

NS

NS

NS

0.65

 

Thrombocytopenia

43

0.6

NS

NS

NS

NS

0.52

 

Cardiovascular disease

849

12.0

659

11.2

190

16.4

< 0.0001

  1. Treatment consisted of chemo-immunotherapy, radiation therapy, or both
  2. NS: Not shown due to at least one cell in the characteristic with < 11 observations